透景生命
(300642)
| 流通市值：22.31亿 | | | 总市值：26.29亿 |
| 流通股本：1.38亿 | | | 总股本：1.62亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 187,343,878.56 | 82,608,916.07 | 363,829,000.98 | 257,613,224.35 |
| 营业收入 | 187,343,878.56 | 82,608,916.07 | 363,829,000.98 | 257,613,224.35 |
| 利息收入 | 0 | 0 | - | - |
| 已赚保费 | 0 | 0 | - | - |
| 手续费及佣金收入 | 0 | 0 | - | - |
| 二、营业总成本 | 180,890,732.86 | 86,541,401.46 | 331,031,793.5 | 237,122,494.65 |
| 营业成本 | 61,754,615.55 | 29,018,632.4 | 110,755,905.67 | 86,054,550.82 |
| 税金及附加 | 2,197,896.55 | 969,248.06 | 4,185,559.37 | 3,265,167.76 |
| 销售费用 | 60,416,677.58 | 31,556,057.27 | 116,410,849.22 | 80,178,823.62 |
| 管理费用 | 22,666,208.59 | 10,836,317.15 | 43,064,536.63 | 30,967,036.28 |
| 研发费用 | 30,080,381.5 | 12,680,987.92 | 58,463,064.42 | 39,990,947.86 |
| 财务费用 | 3,774,953.09 | 1,480,158.66 | -1,848,121.81 | -3,334,031.69 |
| 其中:利息费用 | - | - | 2,564,359.35 | 429,333.15 |
| 其中:利息收入 | - | - | 5,466,346.36 | 4,573,783.94 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 4,974,056.13 | 709,422.05 | 1,653,596.77 | 726,383.1 |
| 加:投资收益 | -5,991,797.82 | -3,708,260.76 | -10,233,848.21 | -6,049,434.19 |
| 汇兑收益 | 0 | 0 | - | - |
| 资产处置收益 | 0 | 0 | -19,184.87 | -3,950.86 |
| 资产减值损失(新) | -4,039,937.59 | 2,398.81 | -14,625,212.26 | -3,424,364.04 |
| 信用减值损失(新) | 12,575,753.11 | 410,168.1 | -19,258,325.15 | -12,578,990.17 |
| 其他收益 | 2,736,729.99 | 671,492.26 | 7,555,190.47 | 4,022,602.4 |
| 四、营业利润 | 16,707,949.52 | -5,847,264.93 | -2,130,575.77 | 3,182,975.94 |
| 加:营业外收入 | 3,747.94 | 0.63 | 246,363.53 | 228,363.52 |
| 减:营业外支出 | 1,982,500.1 | 533.76 | 997,726.07 | 293,394.78 |
| 五、利润总额 | 14,729,197.36 | -5,847,798.06 | -2,881,938.31 | 3,117,944.68 |
| 减:所得税费用 | 3,950,144.61 | 402,280.45 | -2,057,541.26 | 278,162.4 |
| 六、净利润 | 10,779,052.75 | -6,250,078.51 | -824,397.05 | 2,839,782.28 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 10,779,052.75 | -6,250,078.51 | -824,397.05 | 2,839,782.28 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 11,476,529.73 | -5,560,762.85 | 3,587,909.07 | 5,774,947.62 |
| 少数股东损益 | -697,476.98 | -689,315.66 | -4,412,306.12 | -2,935,165.34 |
| 扣除非经常损益后的净利润 | 5,952,393.12 | -6,986,985.53 | -5,882,613.86 | 1,373,249.07 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.07 | -0.03 | 0.02 | 0.04 |
| (二)稀释每股收益 | 0.07 | -0.03 | 0.02 | 0.04 |
| 八、其他综合收益 | -36,511.74 | 71,447.84 | -874,541.22 | 220,689.42 |
| 归属于母公司股东的其他综合收益 | -36,511.74 | 71,447.84 | -874,541.22 | 220,689.42 |
| 九、综合收益总额 | 10,742,541.01 | -6,178,630.67 | -1,698,938.27 | 3,060,471.7 |
| 归属于母公司股东的综合收益总额 | 11,440,017.99 | -5,489,315.01 | 2,713,367.85 | 5,995,637.04 |
| 归属于少数股东的综合收益总额 | -697,476.98 | -689,315.66 | -4,412,306.12 | -2,935,165.34 |
| 公告日期 | 2026-08-25 | 2026-04-25 | 2026-04-25 | 2025-10-23 |
| 审计意见(境内) | | | 标准无保留意见 | |